Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
GM Frampton, A Fichtenholtz, GA Otto, K Wang… - Nature …, 2013 - nature.com
As more clinically relevant cancer genes are identified, comprehensive diagnostic
approaches are needed to match patients to therapies, raising the challenge of optimization …
approaches are needed to match patients to therapies, raising the challenge of optimization …
Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
GM Frampton, A Fichtenholtz, GA Otto… - Nature …, 2013 - pubmed.ncbi.nlm.nih.gov
As more clinically relevant cancer genes are identified, comprehensive diagnostic
approaches are needed to match patients to therapies, raising the challenge of optimization …
approaches are needed to match patients to therapies, raising the challenge of optimization …
Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing.
GM Frampton, A Fichtenholtz, GA Otto… - Nature …, 2013 - search.ebscohost.com
As more clinically relevant cancer genes are identified, comprehensive diagnostic
approaches are needed to match patients to therapies, raising the challenge of optimization …
approaches are needed to match patients to therapies, raising the challenge of optimization …
Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing.
GM Frampton, A Fichtenholtz, GA Otto, K Wang… - Nature …, 2013 - europepmc.org
As more clinically relevant cancer genes are identified, comprehensive diagnostic
approaches are needed to match patients to therapies, raising the challenge of optimization …
approaches are needed to match patients to therapies, raising the challenge of optimization …
Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
GM Frampton, A Fichtenholtz, GA Otto, K Wang… - Nature …, 2013 - go.gale.com
As more clinically relevant cancer genes are identified, comprehensive diagnostic
approaches are needed to match patients to therapies, raising the challenge of optimization …
approaches are needed to match patients to therapies, raising the challenge of optimization …
[HTML][HTML] Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
GM Frampton, A Fichtenholtz, GA Otto… - Nature …, 2013 - ncbi.nlm.nih.gov
As more clinically relevant cancer genes are identified, comprehensive diagnostic
approaches are needed to match patients to therapies, raising the challenge of optimization …
approaches are needed to match patients to therapies, raising the challenge of optimization …
Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
GM Frampton, A Fichtenholtz, GA Otto, K Wang… - Nature …, 2013 - nature.com
As more clinically relevant cancer genes are identified, comprehensive diagnostic
approaches are needed to match patients to therapies, raising the challenge of optimization …
approaches are needed to match patients to therapies, raising the challenge of optimization …
[引用][C] Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
GM Frampton, A Fichtenholtz, GA Otto, K Wang… - Nature …, 2013 - cir.nii.ac.jp
Development and validation of a clinical cancer genomic profiling test based on massively
parallel DNA sequencing | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …
parallel DNA sequencing | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …
Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing.
GM Frampton, A Fichtenholtz, GA Otto… - Nature …, 2013 - search.ebscohost.com
As more clinically relevant cancer genes are identified, comprehensive diagnostic
approaches are needed to match patients to therapies, raising the challenge of optimization …
approaches are needed to match patients to therapies, raising the challenge of optimization …
Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing.
GM Frampton, A Fichtenholtz, GA Otto, K Wang… - Nature …, 2013 - europepmc.org
As more clinically relevant cancer genes are identified, comprehensive diagnostic
approaches are needed to match patients to therapies, raising the challenge of optimization …
approaches are needed to match patients to therapies, raising the challenge of optimization …